Drug Development

Sonus Pharmaceuticals Highlights Progress and Reports First Quarter Financial Results

Published in Cancer Weekly, May 22nd, 2007

Sonus Pharmaceuticals, Inc. (NASDAQ: SNUS), an oncology drug development company, reported progress and financial results for the first quarter of 2007. At 4:30 P.M. ET today, Sonus will host its quarterly conference call. The discussion will include an overview of the progress with the Company's first two oncology product candidates, TOCOSOL(R) Paclitaxel and TOCOSOL Camptothecin.

"During the first quarter, we continued to focus on our primary objectives for 2007, and at this point in the year, we believe that we are on track to achieve those objectives," said Michael A. Martino, President and Chief Executive Officer of Sonus Pharmaceuticals. "First, the Phase 3...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2007-05-22)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry